ESOU 2019: Adjuvant therapy after nephrectomy for high-risk renal cell carcinoma
The following presentations were given at the European Association of [...]
ESOU 2019: First-line treatment for metastatic renal cell carcinoma – where do we stand?
The following review of the literature for first-line treatment of [...]
Advances and next steps in kidney cancer
In an interview with OncLive, Dr Toni Choueiri from Harvard Medical [...]
Promising avelumab plus axitinib data in renal cell carcinoma
The following OncLive interview with leading renal cell carcinoma (RCC) expert, Dr [...]
Historical outcomes in metastatic renal cell carcinoma
The following OncLive video interview with two leading renal cell carcinoma [...]
What the future may hold for the treatment of renal cell carcinoma
The following article from OncLive discusses the rapidly changing landscape in [...]
Immunotherapy combinations for advanced kidney cancer
The following two videos from OncLive are interviews with two [...]
Active smoking shortens overall survival in metastatic kidney cancer patients treated with TKIs
We already know that smoking may increase the risk of [...]
The implications of germline mutations in kidney cancer
A recent article in JAMA Oncology, published this month, discusses [...]
Tyrosine kinase inhibitors for kidney cancer: Past, present and future
In his keynote lecture at the American Society for Clinical Oncology Genitourinary [...]
